Humanin

Source / Derivation:

Humanin is a synthetic peptide derived from a mitochondrial-encoded micropeptide originally discovered for its cytoprotective and anti-apoptotic properties. It is produced to replicate the endogenous peptide’s role in protecting cells from metabolic and oxidative stress.

Humanin

Mechanism of Action:

Humanin interacts with cell surface and intracellular receptors, modulating apoptotic pathways, improving mitochondrial function, and reducing oxidative stress. It also supports metabolic regulation and cellular survival under stress conditions. Additionally, Humanin may enhance tissue resilience and repair mechanisms.

Clinical Relevance & Potential Outcomes:

Research suggests Humanin may support cell survival, mitochondrial efficiency, and resistance to metabolic or oxidative stress. It has been explored for potential applications in age-related diseases, neurodegenerative disorders, and metabolic dysfunction. Clinical evidence indicates it may improve cellular resilience and overall tissue health.

Intended Clinical Application:

Humanin may be relevant for patients requiring mitochondrial protection, anti-apoptotic support, or cellular resilience enhancement. It may also be considered in preventive and regenerative health strategies.

Formulation & Quality Specifications:

Delivered as a liquid prefilled pen
Purity: >98% (HPLC-validated)
Storage: 2–8 °C (refrigerated)
Documentation: Full CoA and MSDS available

Concentration:

Frequency:

Dosage (pen clicks):

Duration:

Notes:

10 mg/ml, total 3 ml, total 30 mg

Daily

1 month

Humanin improves mitochondrial function and protects against aging. Regular cycles with breaks are recommended